单位:[1]Capital Med Univ, Liver Res Ctr, Beijing Friendship Hosp, 95 Yong An Rd, Beijing 100050, Peoples R China临床科室国家中心肝病分中心首都医科大学附属北京友谊医院[2]Beijing Key Lab Translat Med Liver Cirrhosis, 95 Yong An Rd, Beijing 100050, Peoples R China[3]Natl Clin Res Ctr Digest Dis, Beijing 100050, Peoples R China首都医科大学附属北京友谊医院[4]Capital Med Univ, Beijing Friendship Hosp, Expt Ctr, Beijing 100050, Peoples R China首都医科大学附属北京友谊医院
Backgrounds Hereditary hemochromatosis (HH) is mainly caused by homozygous p.C282Y mutations in HFE in the Caucasians. We recently reported non-HFE mutations constitute the major cause of HH in Chinese. However, there is still a relatively high proportion of cases with primary iron overload from unexplained causes. We aimed to explore novel non-HFE mutations in Chinese patients with primary iron overload. Methods Whole exome sequence was conducted to screen mutations in novel HH-related genes in the 9 cases with unexplained primary iron overload. Then the representative candidate genes were screened for mutations in another cohort of 18 HH cases. The biological function of the selected genes and variants were analyzed in vitro. Results Whole exome sequencing of 9 cases with unexplained primary iron overload identified 42 missense variants in 40 genes associated with iron metabolism pathway genes such as UBE2O p.K689R and PCSK7 p.R711W. Subsequent Sanger sequencing of the UBE2O and PCSK7 genes in the 27 cases with primary iron overload identified p.K689R in UBE2O, p.R711W and p.V143F in PCSK7 at frequency of 2/27,1/27 and 2/27 respectively. In vitro siRNA interference of UBE2O and PCSK7 resulted in down-regulated HAMP mRNA expression. Adenovirus generation of UBE2O p.K689R in cell lines resulted in increased expression of SMAD6 and SMAD7 and downregulation of p-SMAD1/5 and HAMP expression, and the reduction of hepcidin level. Conclusions Our study identified a series of novel candidate non-HFE mutations in Chinese patients with HH. These may provide insights into the genetic basis of unexplained primary iron overload.
基金:
National Natural Science Foundation of China [82070598]; Beijing Municipal Administration of Hospitals' Youth Programme [QML20190105]; Digestive Medical Coordinated Development Center of Beijing Hospitals Authority [XXZ0502, XXX0101]
语种:
外文
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2021]版:
大类|2 区医学
小类|3 区遗传学3 区医学:研究与实验
最新[2025]版:
大类|2 区医学
小类|2 区遗传学2 区医学:研究与实验
JCR分区:
出版当年[2020]版:
Q2GENETICS & HEREDITYQ2MEDICINE, RESEARCH & EXPERIMENTAL
最新[2023]版:
Q2GENETICS & HEREDITYQ2MEDICINE, RESEARCH & EXPERIMENTAL
第一作者单位:[1]Capital Med Univ, Liver Res Ctr, Beijing Friendship Hosp, 95 Yong An Rd, Beijing 100050, Peoples R China[2]Beijing Key Lab Translat Med Liver Cirrhosis, 95 Yong An Rd, Beijing 100050, Peoples R China[3]Natl Clin Res Ctr Digest Dis, Beijing 100050, Peoples R China
通讯作者:
通讯机构:[1]Capital Med Univ, Liver Res Ctr, Beijing Friendship Hosp, 95 Yong An Rd, Beijing 100050, Peoples R China[2]Beijing Key Lab Translat Med Liver Cirrhosis, 95 Yong An Rd, Beijing 100050, Peoples R China[3]Natl Clin Res Ctr Digest Dis, Beijing 100050, Peoples R China[4]Capital Med Univ, Beijing Friendship Hosp, Expt Ctr, Beijing 100050, Peoples R China
推荐引用方式(GB/T 7714):
Zhang Wei,Li Yanmeng,Xu Anjian,et al.Identification of novel non-HFE mutations in Chinese patients with hereditary hemochromatosis[J].ORPHANET JOURNAL of RARE DISEASES.2022,17(1):doi:10.1186/s13023-022-02349-y.
APA:
Zhang, Wei,Li, Yanmeng,Xu, Anjian,Ouyang, Qin,Wu, Liyan...&Jia, Jidong.(2022).Identification of novel non-HFE mutations in Chinese patients with hereditary hemochromatosis.ORPHANET JOURNAL of RARE DISEASES,17,(1)
MLA:
Zhang, Wei,et al."Identification of novel non-HFE mutations in Chinese patients with hereditary hemochromatosis".ORPHANET JOURNAL of RARE DISEASES 17..1(2022)